Related Experiment Video
Updated: Mar 25, 2026

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
Central N/OFQ-NOP Receptor System in Pain Modulation
Norikazu Kiguchi1, Huiping Ding1, Mei-Chuan Ko1
1Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) system modulates pain differently in rodents and primates. NOP agonists offer potential safe analgesics, unlike traditional opioids, with fewer side effects in humans.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- The nociceptin/orphanin FQ (N/OFQ) peptide and its cognate (NOP) receptor were discovered two decades ago.
- NOP receptor activation shares intracellular signaling pathways with mu-opioid (MOP) receptors.
- NOP receptor-mediated pain modulation is complex and differs significantly between species.
Purpose of the Study:
- To review functional evidence on the role of NOP receptor agonists in pain modulation.
- To compare the effects of NOP receptor agonists in rodents and nonhuman primates.
- To evaluate the therapeutic potential and safety profile of NOP receptor agonists as analgesics.
Main Methods:
- Review of functional evidence from studies on spinal, supraspinal, and systemic administration of NOP receptor agonists.
- Analysis of pain modulation effects across different doses, assays, and pain modalities in rodents.
- Examination of NOP receptor agonist effects in nonhuman primates, including side effect profiles.
Main Results:
- Rodent studies show bidirectional pain modulation by NOP receptor agonists, dependent on dose and pain type.
- Nonhuman primate studies consistently demonstrate antinociception and antihypersensitivity with NOP receptor agonists.
- NOP receptor agonists and some bifunctional agonists lack abuse liability, respiratory depression, and gastrointestinal side effects in primates.
Conclusions:
- NOP receptor agonists exhibit a wider therapeutic window than MOP receptor agonists in primates.
- Bifunctional NOP/MOP receptor agonists require further investigation for their side effect profiles.
- Selective NOP receptor agonists and bifunctional agonists show promise as safe and effective analgesics for human use.
Related Concept Videos
Nociception
Opioid Receptors: Overview
Analgesia and Pain Management
Pain
Thermosensation
Sensory Perception: Organization of the Somatosensory System
The receptor level:
The receptor level is the first stage of sensation. It involves the detection of a stimulus by specialized sensory receptors. The stimulus must arrive within the receptor's receptive field. Next, the receptor converts the energy of the...

